位置:首页 > 蛋白库 > YKT6_HUMAN
YKT6_HUMAN
ID   YKT6_HUMAN              Reviewed;         198 AA.
AC   O15498; B4DR94; Q53F01; Q6FGU9; Q6IB15;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   03-AUG-2022, entry version 170.
DE   RecName: Full=Synaptobrevin homolog YKT6;
DE            EC=2.3.1.- {ECO:0000269|PubMed:15479160};
DE   Flags: Precursor;
GN   Name=YKT6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Pancreas;
RX   PubMed=9211930; DOI=10.1074/jbc.272.28.17776;
RA   McNew J.A., Soegaard M., Lampen N.M., Machida S., Ye R.R., Lacomis L.,
RA   Tempst P., Rothman J.E., Soellner T.H.;
RT   "Ykt6p, a prenylated SNARE essential for endoplasmic reticulum-Golgi
RT   transport.";
RL   J. Biol. Chem. 272:17776-17783(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hepatoma;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF PHE-42; CYS-194 AND CYS-195, AND
RP   PALMITOYLATION AT CYS-194.
RX   PubMed=15479160; DOI=10.1042/bj20041474;
RA   Veit M.;
RT   "The human SNARE protein Ykt6 mediates its own palmitoylation at C-terminal
RT   cysteine residues.";
RL   Biochem. J. 384:233-237(2004).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=14742712; DOI=10.1091/mbc.e03-08-0625;
RA   Volchuk A., Ravazzola M., Perrelet A., Eng W.S., Di Liberto M.,
RA   Varlamov O., Fukasawa M., Engel T., Sollner T.H., Rothman J.E., Orci L.;
RT   "Countercurrent distribution of two distinct SNARE complexes mediating
RT   transport within the Golgi stack.";
RL   Mol. Biol. Cell 15:1506-1518(2004).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15215310; DOI=10.1091/mbc.e03-12-0876;
RA   Tai G., Lu L., Wang T.L., Tang B.L., Goud B., Johannes L., Hong W.;
RT   "Participation of the syntaxin 5/Ykt6/GS28/GS15 SNARE complex in transport
RT   from the early/recycling endosome to the trans-Golgi network.";
RL   Mol. Biol. Cell 15:4011-4022(2004).
RN   [11]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF PHE-42; CYS-194 AND CYS-195,
RP   ISOPRENYLATION AT CYS-195, AND PALMITOYLATION.
RX   PubMed=15044687; DOI=10.1073/pnas.0401183101;
RA   Fukasawa M., Varlamov O., Eng W.S., Soellner T.H., Rothman J.E.;
RT   "Localization and activity of the SNARE Ykt6 determined by its regulatory
RT   domain and palmitoylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:4815-4820(2004).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Vesicular soluble NSF attachment protein receptor (v-SNARE)
CC       mediating vesicle docking and fusion to a specific acceptor cellular
CC       compartment. Functions in endoplasmic reticulum to Golgi transport; as
CC       part of a SNARE complex composed of GOSR1, GOSR2 and STX5. Functions in
CC       early/recycling endosome to TGN transport; as part of a SNARE complex
CC       composed of BET1L, GOSR1 and STX5. Has a S-palmitoyl transferase
CC       activity. {ECO:0000269|PubMed:15215310, ECO:0000269|PubMed:9211930}.
CC   -!- SUBUNIT: Identified in 2 different SNARE complexes; the first one
CC       composed of GOSR1, GOSR2 and STX5 and the second one composed of BET1L,
CC       GOSR1 and STX5. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasmic vesicle membrane;
CC       Lipid-anchor; Cytoplasmic side. Golgi apparatus membrane; Lipid-anchor;
CC       Cytoplasmic side. Note=Probably cycles through vesicles between Golgi
CC       and endosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15498-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15498-2; Sequence=VSP_056071;
CC   -!- DOMAIN: The longin domain regulates palmitoylation and membrane
CC       targeting.
CC   -!- PTM: Palmitoylated; catalyzes its own palmitoylation. Palmitoylation is
CC       required for Golgi targeting. {ECO:0000269|PubMed:15044687,
CC       ECO:0000269|PubMed:15479160}.
CC   -!- PTM: Farnesylation is required for Golgi targeting.
CC   -!- SIMILARITY: Belongs to the synaptobrevin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U95735; AAB81131.1; -; mRNA.
DR   EMBL; BT007078; AAP35741.1; -; mRNA.
DR   EMBL; AK299158; BAG61206.1; -; mRNA.
DR   EMBL; CR456989; CAG33270.1; -; mRNA.
DR   EMBL; CR542008; CAG46805.1; -; mRNA.
DR   EMBL; AK223488; BAD97208.1; -; mRNA.
DR   EMBL; AC006454; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC007319; AAH07319.1; -; mRNA.
DR   CCDS; CCDS5482.1; -. [O15498-1]
DR   CCDS; CCDS87497.1; -. [O15498-2]
DR   RefSeq; NP_006546.1; NM_006555.3. [O15498-1]
DR   RefSeq; XP_016867171.1; XM_017011682.1.
DR   PDB; 6J74; X-ray; 3.21 A; C=1-198.
DR   PDB; 6J7F; X-ray; 2.88 A; C=1-195.
DR   PDB; 6J7X; X-ray; 2.75 A; C=1-198.
DR   PDBsum; 6J74; -.
DR   PDBsum; 6J7F; -.
DR   PDBsum; 6J7X; -.
DR   AlphaFoldDB; O15498; -.
DR   SMR; O15498; -.
DR   BioGRID; 115895; 217.
DR   IntAct; O15498; 38.
DR   MINT; O15498; -.
DR   STRING; 9606.ENSP00000223369; -.
DR   TCDB; 1.F.1.3.1; the synaptosomal vesicle fusion pore (svf-pore) family.
DR   iPTMnet; O15498; -.
DR   PhosphoSitePlus; O15498; -.
DR   SwissPalm; O15498; -.
DR   BioMuta; YKT6; -.
DR   EPD; O15498; -.
DR   jPOST; O15498; -.
DR   MassIVE; O15498; -.
DR   MaxQB; O15498; -.
DR   PaxDb; O15498; -.
DR   PeptideAtlas; O15498; -.
DR   PRIDE; O15498; -.
DR   ProteomicsDB; 48697; -. [O15498-1]
DR   ProteomicsDB; 4936; -.
DR   TopDownProteomics; O15498-1; -. [O15498-1]
DR   Antibodypedia; 27085; 73 antibodies from 17 providers.
DR   DNASU; 10652; -.
DR   Ensembl; ENST00000223369.3; ENSP00000223369.2; ENSG00000106636.9. [O15498-1]
DR   Ensembl; ENST00000496112.5; ENSP00000420805.1; ENSG00000106636.9. [O15498-2]
DR   Ensembl; ENST00000679020.1; ENSP00000504623.1; ENSG00000106636.9. [O15498-1]
DR   GeneID; 10652; -.
DR   KEGG; hsa:10652; -.
DR   MANE-Select; ENST00000223369.3; ENSP00000223369.2; NM_006555.4; NP_006546.1.
DR   UCSC; uc003tkm.4; human. [O15498-1]
DR   CTD; 10652; -.
DR   DisGeNET; 10652; -.
DR   GeneCards; YKT6; -.
DR   HGNC; HGNC:16959; YKT6.
DR   HPA; ENSG00000106636; Low tissue specificity.
DR   MIM; 606209; gene.
DR   neXtProt; NX_O15498; -.
DR   OpenTargets; ENSG00000106636; -.
DR   PharmGKB; PA145007308; -.
DR   VEuPathDB; HostDB:ENSG00000106636; -.
DR   eggNOG; KOG0861; Eukaryota.
DR   GeneTree; ENSGT00390000015164; -.
DR   HOGENOM; CLU_074848_3_0_1; -.
DR   InParanoid; O15498; -.
DR   OMA; ITDHEYP; -.
DR   PhylomeDB; O15498; -.
DR   TreeFam; TF105606; -.
DR   PathwayCommons; O15498; -.
DR   Reactome; R-HSA-204005; COPII-mediated vesicle transport.
DR   Reactome; R-HSA-6807878; COPI-mediated anterograde transport.
DR   Reactome; R-HSA-6811438; Intra-Golgi traffic.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013148; CDC42 GTPase cycle.
DR   Reactome; R-HSA-9013149; RAC1 GTPase cycle.
DR   Reactome; R-HSA-9013408; RHOG GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   SignaLink; O15498; -.
DR   BioGRID-ORCS; 10652; 750 hits in 1086 CRISPR screens.
DR   ChiTaRS; YKT6; human.
DR   GeneWiki; YKT6; -.
DR   GenomeRNAi; 10652; -.
DR   Pharos; O15498; Tbio.
DR   PRO; PR:O15498; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; O15498; protein.
DR   Bgee; ENSG00000106636; Expressed in stromal cell of endometrium and 189 other tissues.
DR   ExpressionAtlas; O15498; baseline and differential.
DR   Genevisible; O15498; HS.
DR   GO; GO:0097440; C:apical dendrite; IEA:Ensembl.
DR   GO; GO:0097441; C:basal dendrite; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HGNC-UCL.
DR   GO; GO:0033116; C:endoplasmic reticulum-Golgi intermediate compartment membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:HGNC-UCL.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HGNC-UCL.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:HGNC-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0031201; C:SNARE complex; ISS:HGNC-UCL.
DR   GO; GO:0030133; C:transport vesicle; TAS:Reactome.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0019706; F:protein-cysteine S-palmitoyltransferase activity; IDA:HGNC-UCL.
DR   GO; GO:0005484; F:SNAP receptor activity; IDA:HGNC-UCL.
DR   GO; GO:0006888; P:endoplasmic reticulum to Golgi vesicle-mediated transport; IDA:HGNC-UCL.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IDA:HGNC-UCL.
DR   GO; GO:0006904; P:vesicle docking involved in exocytosis; IDA:HGNC-UCL.
DR   GO; GO:0006903; P:vesicle targeting; IDA:HGNC-UCL.
DR   CDD; cd14824; Longin; 1.
DR   CDD; cd15867; R-SNARE_YKT6; 1.
DR   InterPro; IPR011012; Longin-like_dom_sf.
DR   InterPro; IPR010908; Longin_dom.
DR   InterPro; IPR045848; R-SNARE_YKT6.
DR   InterPro; IPR042855; V_SNARE_CC.
DR   Pfam; PF13774; Longin; 1.
DR   Pfam; PF00957; Synaptobrevin; 1.
DR   SMART; SM01270; Longin; 1.
DR   SUPFAM; SSF64356; SSF64356; 1.
DR   PROSITE; PS50859; LONGIN; 1.
DR   PROSITE; PS50892; V_SNARE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Cytoplasm;
KW   Cytoplasmic vesicle; ER-Golgi transport; Golgi apparatus; Lipoprotein;
KW   Membrane; Methylation; Palmitate; Phosphoprotein; Prenylation;
KW   Protein transport; Reference proteome; Transferase; Transport.
FT   CHAIN           1..195
FT                   /note="Synaptobrevin homolog YKT6"
FT                   /id="PRO_0000280709"
FT   PROPEP          196..198
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000396661"
FT   DOMAIN          8..126
FT                   /note="Longin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00231"
FT   DOMAIN          138..198
FT                   /note="v-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00290"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         195
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000305"
FT   LIPID           194
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:15479160"
FT   LIPID           195
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000269|PubMed:15044687"
FT   VAR_SEQ         154..187
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056071"
FT   MUTAGEN         42
FT                   /note="F->E: Increases palmitoylation. Targeted to Golgi
FT                   membranes. Targeted to Golgi and cytosol; when associated
FT                   with S-194. Targeted to cytosol; when associated with S-
FT                   195."
FT                   /evidence="ECO:0000269|PubMed:15044687,
FT                   ECO:0000269|PubMed:15479160"
FT   MUTAGEN         194
FT                   /note="C->S: Decreases palmitoylation by 55%. Prevents
FT                   palmitoylation; when associated with S-195. Targeted to
FT                   Golgi and cytosol; when associated with E-42."
FT                   /evidence="ECO:0000269|PubMed:15044687,
FT                   ECO:0000269|PubMed:15479160"
FT   MUTAGEN         195
FT                   /note="C->S: Prevents farnesylation. Targeted to cytosol;
FT                   when associated with E-42. Decreases palmitoylation by 13%.
FT                   Prevents palmitoylation; when associated with S-194."
FT                   /evidence="ECO:0000269|PubMed:15044687,
FT                   ECO:0000269|PubMed:15479160"
FT   CONFLICT        63
FT                   /note="D -> N (in Ref. 4; CAG46805)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        138
FT                   /note="P -> L (in Ref. 5; BAD97208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        198
FT                   /note="M -> I (in Ref. 4; CAG33270)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..11
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          16..20
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          26..28
FT                   /evidence="ECO:0007829|PDB:6J74"
FT   HELIX           30..32
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   HELIX           33..50
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          55..61
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          64..70
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          72..81
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   HELIX           87..104
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          107..110
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   TURN            115..117
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   HELIX           123..129
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   TURN            140..144
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          152..156
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   TURN            157..160
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   HELIX           167..173
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   HELIX           179..186
FT                   /evidence="ECO:0007829|PDB:6J7X"
FT   TURN            187..191
FT                   /evidence="ECO:0007829|PDB:6J7X"
SQ   SEQUENCE   198 AA;  22418 MW;  2AB0C12832D1B943 CRC64;
     MKLYSLSVLY KGEAKVVLLK AAYDVSSFSF FQRSSVQEFM TFTSQLIVER SSKGTRASVK
     EQDYLCHVYV RNDSLAGVVI ADNEYPSRVA FTLLEKVLDE FSKQVDRIDW PVGSPATIHY
     PALDGHLSRY QNPREADPMT KVQAELDETK IILHNTMESL LERGEKLDDL VSKSEVLGTQ
     SKAFYKTARK QNSCCAIM
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024